See more : Falcon Oil & Gas Ltd. (FOG.L) Income Statement Analysis – Financial Results
Complete financial analysis of Greenrose Acquisition Corp. (GNRSW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Greenrose Acquisition Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- ENNOSTAR Inc. (3714.TW) Income Statement Analysis – Financial Results
- Parex Resources Inc. (PARXF) Income Statement Analysis – Financial Results
- Avalo Therapeutics, Inc. (AVTX) Income Statement Analysis – Financial Results
- M3-Brigade Acquisition II Corp. (MBAC) Income Statement Analysis – Financial Results
- Cadillac Ventures Inc. (CADIF) Income Statement Analysis – Financial Results
Greenrose Acquisition Corp. (GNRSW)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About Greenrose Acquisition Corp.
Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 0.00 | 25.40M | 28.38M | 0.00 |
| Cost of Revenue | 0.00 | 10.40M | 1.60M | 0.00 |
| Gross Profit | 0.00 | 15.00M | 26.78M | 0.00 |
| Gross Profit Ratio | 0.00% | 59.05% | 94.37% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 22.26K | 1.60M | 0.00 |
| Selling & Marketing | 0.00 | 120.00 | 333.00K | 0.00 |
| SG&A | 0.00 | 5.16M | 1.60M | 6.60 |
| Other Expenses | 0.00 | 0.00 | 63.00K | 0.00 |
| Operating Expenses | 0.00 | 5.16M | 1.60M | 6.60 |
| Cost & Expenses | 0.00 | 15.56M | 1.60M | 6.60 |
| Interest Income | 0.00 | 23.96K | 1.16M | 0.00 |
| Interest Expense | 0.00 | 2.20M | 102.00K | 0.00 |
| Depreciation & Amortization | 228.49K | 1.37M | 992.00K | 171.86K |
| EBITDA | 0.00 | 18.33M | 16.61M | 6.60 |
| EBITDA Ratio | 0.00% | 47.08% | -5.63% | 0.00% |
| Operating Income | 0.00 | 9.84M | -1.60M | -6.60 |
| Operating Income Ratio | 0.00% | 38.74% | -5.63% | 0.00% |
| Total Other Income/Expenses | 0.00 | 9.06M | -16.06M | 0.00 |
| Income Before Tax | 0.00 | 18.90M | -441.98K | -6.60 |
| Income Before Tax Ratio | 0.00% | 74.42% | -1.56% | 0.00% |
| Income Tax Expense | 0.00 | 972.00K | -1.16M | -2.19K |
| Net Income | 0.00 | 17.93M | 714.63K | -6.60 |
| Net Income Ratio | 0.00% | 70.59% | 2.52% | 0.00% |
| EPS | 0.00 | 1.12 | 3.46 | 0.00 |
| EPS Diluted | 0.00 | 1.12 | 3.46 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 16.06M | 206.76K | 3.75K |
| Weighted Avg Shares Out (Dil) | 0.00 | 16.06M | 206.76K | 3.75K |
Source: https://incomestatements.info
Category: Stock Reports